Cargando…
Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema
Women treated for breast cancer are facing a lifetime risk of developing lymphedema, which occurs in up to 40% of this population. There is a lack of evidence and limited knowledge regarding the treatment of breast cancer–related lymphedema (BCRL). The aim of this study was to identify, describe, an...
Autores principales: | Al-Sakkaf, Ali M., Masia, Jaume, Auladell-Rispau, Ariadna, Shamardal, Aliaa I., Vasconcello-Castillo, Luis, Sola, Ivan, Bonfill, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769095/ https://www.ncbi.nlm.nih.gov/pubmed/35070599 http://dx.doi.org/10.1097/GOX.0000000000004045 |
Ejemplares similares
-
The Dynamic Lymphaticovenular Anastomosis for Breast Cancer–related Lymphedema without Compression: Salvaging Lymphedema Patients Who Lost Conservative Treatment Opportunity
por: Seki, Yukio, et al.
Publicado: (2023) -
Outcome Analysis of Combined Surgical Approaches in Advanced-stage Upper Extremity Breast Cancer-related Lymphedema
por: Myung, Yujin, et al.
Publicado: (2023) -
Power-assisted Liposuction for Lymphedema: A Cost-utility Analysis
por: Bloom, Joshua A., et al.
Publicado: (2022) -
Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain
por: Bonfill-Cosp, Xavier, et al.
Publicado: (2022) -
Prevention, Diagnosis, and Management of Upper Extremity Lymphedema Complications: Altmetric Analysis of Online Media
por: Kirloskar, Kunal M., et al.
Publicado: (2022)